Exor loses EUR 2.0 billion on Stellantis while rebuilding its capacity to invest

On 22 September 2026, Exor reported a half-year in which its Stellantis stake lost EUR 2.016 billion in value. In the same accounts, dated 30 June, cash rose by EUR 771 million. The holding company has less market value in one asset, yet more financial freedom. Both statements are true.

Exor is the Agnelli family's listed investment company. It holds stakes in Ferrari, Philips, CNH and Stellantis, among others, and owns the investment manager Lingotto. An Exor shareholder therefore owns an interest in a portfolio, after deducting the parent's debt and other liabilities. They do not directly own a slice of every plant or the cash held by each underlying company.

Stellantis now weighs less, yet explains most of the fall

Stellantis makes vehicles under brands including Peugeot, Fiat and Jeep. Exor owns 15.5% of its economic rights. It is a reference shareholder, not the operator of Stellantis's factories. The automaker affects Exor through the market value of the stake and any dividends it pays.

At the end of 2025, Exor valued the holding at EUR 4.252bn, or 11.5% of gross asset value. Six months later it was worth EUR 2.236bn, or 6.3%. Gross asset value adds investments and cash before subtracting parent-level liabilities. The EUR 2.016bn movement is the reported change in the value of Exor's stake; it does not mean that Exor paid out that amount or sold its shares.

The decline in Stellantis exceeds the EUR 1.232bn fall in Exor's total NAV over the period. This compares scale, rather than attributing the entire result to one company: CNH added EUR 736m in value, Ferrari EUR 213m and Philips EUR 99m. Other positions fell, while distributions and cash movements also changed the asset base. The four listed stake movements come from the same valuation table, but cannot on their own reconcile total NAV.

Exor has not become a “Stellantis holding” because the stake performed badly. Ferrari remained the largest investment at EUR 12.250bn, or 34.2% of gross assets, on 30 June. Yet the lower Stellantis weight does not erase the damage: it largely reflects the fall in its market value. Stellantis also paid Exor no dividend in H1 2026, versus EUR 306m a year earlier, according to the report.

NAV falls as cash builds

Net asset value, or NAV, is what remains after debt and other parent-company liabilities are taken from gross assets. Exor reported EUR 32.009bn at 30 June, down from EUR 33.241bn at the end of 2025. Per share, NAV moved from EUR 164.4 to EUR 157.9, a 3.9% fall. Exor compares this with an 11.8% rise in the MSCI World Index over the same half-year. That is a published performance comparison, not a like-for-like risk or portfolio comparison.

The simplest reconciliation follows the interim report. Gross assets fell by EUR 1.362bn. Gross debt fell by EUR 17m and other liabilities by EUR 113m. Together, those movements produce the EUR 1.232bn fall in NAV. It is the difference between what the portfolio is worth and what is left for its owners.

Cash increased from EUR 1.408bn to EUR 2.179bn. Exor reports close to EUR 1bn already received from disposals and Iveco's extraordinary dividend. The EUR 427m dividend followed Iveco's sale of its defence business. Counting the sale proceeds again as if Exor directly received the full price would overstate parent-level cash. Conversely, Tata Motors' offer for the rest of Iveco had not yet produced cash at 30 June. We explained the two stages of Iveco's exit in an earlier article.

That is the half-year's apparent paradox: a listed stake can lose market value while the parent company gains cash. Selling some investments turns them into money. It does not automatically make up for the decline in a different holding.

A lower leverage ratio mainly reflects higher cash

Exor reports a loan-to-value ratio, or LTV, of 4.7%, down from 6.9% at the end of 2025. The ratio compares adjusted net debt with the value of assets excluding cash. It could suggest that Exor repaid large amounts of debt. The detailed table tells a different story.

Gross debt barely moved, from EUR 3.708bn to EUR 3.691bn, a fall of EUR 17m. Cash rose by EUR 771m and other liabilities fell by EUR 113m. Exor's adjusted numerator accordingly declined from EUR 2.481bn to EUR 1.580bn. The denominator, gross assets less cash, fell from EUR 35.722bn to EUR 33.589bn. The resulting ratio is 4.7%, subject to the report's rounding. Including outstanding commitments, Exor also discloses an LTV of 6.0%, versus 9.2% at the end of 2025. These are different perimeters.

This balance sheet provides room to act, not a return already earned. It allows Exor to absorb volatility in its holdings or consider an investment, while remaining below its published 15% LTV target. Its free cash flow on its own definition, excluding the extraordinary Iveco dividend, was EUR 413m in H1, versus EUR 589m a year earlier. A one-off rise in cash does not show that every investment is generating more recurring cash.

“EUR 4bn deployable” is not EUR 4bn already in the bank

Exor chief executive John Elkann puts deployable capacity at around EUR 4bn after the Iveco and Welltec exits. That is a forward-looking management indication. The cash balance recorded at 30 June was EUR 2.179bn. Welltec is subject to a signed sale agreement, while the Tata offer for Iveco still follows its timetable. Cash received, expected proceeds and future investment capacity do not belong in the same column.

Exor also announced a buyback of up to EUR 500m before its next results in March. It is a ceiling, not money already spent. Exor had already explained the value of waiting before making another large investment. H1 makes that decision more tangible: buybacks, a new investment comparable in size to Philips, additions to existing holdings, investment through Lingotto and retaining cash compete for the same financial room. Our Iveco analysis traced part of the expected proceeds; the report now measures what had actually reached the balance sheet.

Exor reported a 57.6% discount to NAV at 30 June 2026. At a discount, buying back shares can mechanically lift NAV per remaining share if the purchase price and other assets stay unchanged. That mechanism establishes neither the intrinsic value of the holdings nor the superiority of a buyback over an acquisition. The test is what Exor executes and what it gives up to do so, not the announcement's headline size.

What we still do not know

First, the industrial outcome. Stellantis's 30 June valuation reflects a market price, not the result of its turnaround plan. Future company reports will show whether investment, margins and industrial cash flow support that plan. The question reaches beyond the possible costs at the Brampton plant we covered on 12 September.

Second, the cash actually collected. Iveco's exit must still pass offer settlement and Welltec's sale must close. The next reporting date will let us compare EUR 4bn of indicated capacity with cash, commitments and decisions actually made. The EUR 500m buyback will only reveal its effect on NAV per share once the number of shares bought, the prices paid and competing uses of capital are known.

Exor ends the half-year with a portfolio worth less and a more liquid balance sheet. Cash does not reverse the fall in Stellantis, and that fall does not settle the case for the rest of the portfolio. The next test is the quality of the choices the liquidity makes possible.